Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study. - Ozkerim, Ugur; Isik, Deniz; Kinikoglu, Oguzcan; Oksuz, Sila; Altintas, Yunus Emre; Akdag, Goncagul; Yildirim, Sedat; Basoglu, Tugba; Surmeli, Heves; Odabas, Hatice; Turan, Nedim (Journal of Personalized Medicine, 2026)